Research
-
Predicting Pressure Injury Risk in Hospitalised Patients Using Machine Learning with Electronic Health Records: a US Multilevel Cohort Study
The predictive algorithm with features generated by machine learning achieved significantly improved prediction of pressure injury risk.
Categorized in -
Comparative Effectiveness of Placental Allografts in the Treatment of Diabetic Lower Extremity Ulcers and Venous Leg Ulcers in U.S. Medicare Beneficiaries: A Retrospective Observational Cohort Study Using Real-World Evidence
DLEUs and VLUs treated with vCPM and vLPM allografts are associated with lowered 1-year mortality, wound recurrence, and AOs in DLEUs and VLUs compared with standard care. Decision makers weighing coverage of placental allografts should consider these added short- and long-term clinical benefits relative to costly management and high mortality of Medicare’s most frequent wounds.
Categorized in -
Prevalence of Medical Payment Products Promoted on US Hospitals’ Websites
Research findings suggest that policies limiting hospitals’ promotion of MPPs may need to be coupled with efforts to stabilize hospital finances, as hospitals may be using MPP promotion when they lack the resources to offer long-term interest-free financing.
Categorized in -
Trauma Center Hospitals Charged Higher Prices For Some Nontrauma Care Than Non–Trauma Center Hospitals, 2012–18
Abstract Rising prices are a major cause of increased health care spending and health insurance premiums in the US. Hospital prices, specifically—for both inpatient and outpatient care—are the largest driver of rising health care spending in the commercial insurance market. As a result, policy makers and employers are increasingly interested in understanding the determinants of […]
Categorized in -
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011–20
Part D plans became significantly more restrictive over time, rising from an average of 31.9 percent of compounds restricted in 2011 to 44.4 percent restricted in 2020.
Categorized in -
Analysis of Agreement Between Measures of Subjective Cognitive Impairment and Probable Dementia in the National Health and Aging Trends Study
Subjective cognitive impairment was more prevalent than probable dementia
Categorized in -
Testimony on Pharmaceutical Pricing That Balances Innovation and Affordability for Patients with Rare Diseases
Alice Chen delivered testimony to the House Energy & Commerce Health Subcommittee Hearing pm February 29, 2024.
-
A Principled Approach to Non‑Discrimination in Cost‑Effectiveness
Generalized Risk-Adjusted Cost-Effectiveness (GRACE) offers a choice-consistent alternative that admits a premium for disease severity and avoids prohibited discrimination under well-defined conditions on utility and the effects of disability.
Categorized in -
What Drives Poor Quality of Care for Child Diarrhea? Experimental Evidence from India
Provider misperceptions that patients do not want ORS play the biggest role in the underprescribing of ORS.
Categorized in -
Ensuring Affordable and Valuable Pharmaceutical Innovation for Americans
Aligning drug prices with the actual value provided to patients stimulates innovation that benefits patients and discourages innovation that does not. Legislation to increase drug price transparency, coupled with better information about value, can help payers and consumers spend their money wisely.